Analysen zu SAFRAN S.A.
| 05.11.24 | SAFRAN Overweight | Barclays Capital | |
| 04.11.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 28.10.24 | SAFRAN Hold | Deutsche Bank AG | |
| 25.10.24 | SAFRAN Kaufen | DZ BANK | |
| 25.10.24 | SAFRAN Outperform | RBC Capital Markets | |
| 25.10.24 | SAFRAN Neutral | UBS AG | |
| 25.10.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.10.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 14.10.24 | SAFRAN Outperform | RBC Capital Markets | |
| 08.10.24 | SAFRAN Hold | Deutsche Bank AG | |
| 08.10.24 | SAFRAN Neutral | UBS AG | |
| 27.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.09.24 | SAFRAN Kaufen | DZ BANK | |
| 11.09.24 | SAFRAN Outperform | RBC Capital Markets | |
| 06.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 03.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 02.09.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 22.08.24 | SAFRAN Kaufen | DZ BANK | |
| 12.08.24 | SAFRAN Hold | Deutsche Bank AG | |
| 09.08.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 07.08.24 | SAFRAN Neutral | UBS AG | |
| 31.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 31.07.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 10.07.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 10.07.24 | SAFRAN Hold | Deutsche Bank AG | |
| 04.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 03.07.24 | SAFRAN Neutral | UBS AG | |
| 24.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 20.06.24 | SAFRAN Overweight | Barclays Capital | |
| 17.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 06.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 07.05.24 | SAFRAN Hold | Deutsche Bank AG | |
| 07.05.24 | SAFRAN Overweight | Barclays Capital | |
| 03.05.24 | SAFRAN Halten | DZ BANK | |
| 30.04.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 29.04.24 | SAFRAN Hold | Deutsche Bank AG | |
| 29.04.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.04.24 | SAFRAN Neutral | UBS AG | |
| 26.04.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 26.04.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 12.04.24 | SAFRAN Neutral | UBS AG | |
| 12.04.24 | SAFRAN Hold | Deutsche Bank AG | |
| 10.04.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 25.03.24 | SAFRAN Hold | Deutsche Bank AG | |
| 19.03.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 08.03.24 | SAFRAN Neutral | UBS AG | |
| 06.03.24 | SAFRAN Neutral | UBS AG | |
| 04.03.24 | SAFRAN Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 05.02.26 | Hannover Rück Kaufen | DZ BANK | |
| 05.02.26 | Evonik Equal Weight | Barclays Capital | |
| 05.02.26 | BNP Paribas Buy | UBS AG | |
| 05.02.26 | Vodafone Group Sell | UBS AG | |
| 05.02.26 | Santander Buy | UBS AG | |
| 05.02.26 | ArcelorMittal Neutral | UBS AG | |
| 05.02.26 | Hannover Rück Buy | UBS AG | |
| 05.02.26 | Shell Neutral | UBS AG | |
| 05.02.26 | Prosus Buy | UBS AG | |
| 05.02.26 | BBVA Buy | UBS AG | |
| 05.02.26 | RATIONAL Buy | UBS AG | |
| 05.02.26 | Siemens Healthineers Neutral | UBS AG | |
| 05.02.26 | Evonik Sell | Goldman Sachs Group Inc. | |
| 05.02.26 | BNP Paribas Outperform | RBC Capital Markets | |
| 05.02.26 | Hannover Rück Sector Perform | RBC Capital Markets | |
| 05.02.26 | Shell Sector Perform | RBC Capital Markets | |
| 05.02.26 | RATIONAL Underperform | RBC Capital Markets | |
| 05.02.26 | Vestas Wind Systems A-S Outperform | RBC Capital Markets | |
| 05.02.26 | Santander Halten | DZ BANK | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BNP Paribas Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Hannover Rück Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | Vestas Wind Systems A-S Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Ferrari Overweight | Barclays Capital | |
| 05.02.26 | Beiersdorf Overweight | Barclays Capital | |
| 05.02.26 | Heidelberg Materials Overweight | Barclays Capital | |
| 05.02.26 | Bayer Overweight | Barclays Capital | |
| 05.02.26 | Siemens Healthineers Overweight | Barclays Capital | |
| 05.02.26 | Rheinmetall Overweight | Barclays Capital | |
| 05.02.26 | Hannover Rück Underweight | Barclays Capital | |
| 05.02.26 | Evonik Underperform | Jefferies & Company Inc. | |
| 05.02.26 | RATIONAL Outperform | Bernstein Research | |
| 05.02.26 | Linde Outperform | Bernstein Research | |
| 05.02.26 | Akzo Nobel Market-Perform | Bernstein Research | |
| 05.02.26 | BASF Outperform | Bernstein Research | |
| 05.02.26 | ArcelorMittal Hold | Jefferies & Company Inc. | |
| 05.02.26 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 05.02.26 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 05.02.26 | Vestas Wind Systems A-S Buy | Jefferies & Company Inc. | |
| 05.02.26 | Infineon Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Rheinmetall Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Elmos Semiconductor Buy | Warburg Research | |
| 05.02.26 | Heidelberger Druckmaschinen Hold | Warburg Research | |
| 05.02.26 | RATIONAL Buy | Warburg Research | |
| 05.02.26 | OMV Underweight | Barclays Capital | |
| 05.02.26 | GSK Hold | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.